Supreme Court Rejects Challenge to Mifepristone in FDA v. Alliance
Supreme Court of the United States, 1, 1st Street Northeast, Ward 6, Washington, District of Columbia, 20543, United States
Supreme Court of the United States
CONFIRMED84% CONFIDENCEThe slip opinion in No. 23-235 is headed "Argued March 26, 2024—Decided June 13, 2024".[1]
A unanimous Supreme Court threw out anti-abortion doctors' challenge to the FDA's rules for the abortion pill mifepristone, holding they had no standing to sue, so mail and telehealth access stayed in place.
1.00